Implanon: the subdermal contraceptive implant.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pediatric and Adolescent Gynecology

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JPAG.2010.03.006PMID 21105241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.

  2009cited by this paper
• Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.

  2005cited by this paper
• Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia.

  2005cited by this paper
• Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group

  2004cited by this paper
• Experience with Implanon® in a north-east London family planning clinic

  2004cited by this paper
• Experience with Implanon in a northeast London family planning clinic.

  2004cited by this paper
• Implanon implant detection with ultrasound and magnetic resonance imaging

  2003cited by this paper
• Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies.

  2002cited by this paper
• Implanon. The new alternative.

  2002cited by this paper
• Metabolic effects of implantable steroid contraceptives for women.

  2002cited by this paper
• Implant Contraception

  2001cited by this paper
• Implanon: A Critical Review

  2001cited by this paper
• Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device.

  2000cited by this paper
• Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception.

  2000cited by this paper
• Implanon. A review of clinical studies.

  1999cited by this paper
• A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group.

  1999cited by this paper
• Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.

  1998cited by this paper
• Pharmacokinetics of Implanon. An integrated analysis.

  1998cited by this paper
• An integrated analysis of nonmenstrual adverse events with Implanon.

  1998cited by this paper
• Introduction: Presentation of clinical data on implanon®1

  1998cited by this paper
• Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.

  1998cited by this paper
• An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.

  1998cited by this paper
• Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.

  1997cited by this paper
• Clinical trial with 3-keto-desogestrel subdermal implants.

  1991cited by this paper

• Symptomatic hypotensive episodes following Implanon NXT® insertion: a case report.

  2024cites this paper
• Early discontinuation of the IMPLANON® and associated factors in Ethiopia, systematic review and meta-analysis

  2023cites this paper
• A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients

  2021cites this paper
• Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports

  2021cites this paper
• Entrenamiento para colocación del implante subdérmico anticonceptivo con etonogestrel a residentes del posgrado de pediatría de la Universidad de Costa Rica.

  2020cites this paper
• Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016

  2018cites this paper
• Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

  2016cites this paper
• Social behavioral changes in MPTP-treated monkey model of Parkinson's disease

  2015cites this paper
• FACTORS ASSOCIATED WITH USE AND DISCONTINUATION OF IMPLANON CONTRACEPTIVE IN JOS, NIGERIA

  2015cites this paper
• BODY WEIGHT CHANGES IN WOMEN USING IMPLANON IN JOS, NIGERIA.

  2014cites this paper
• EVAPIL-R Scale: Continuous development and validation of a tool to assess patient-reported tolerability of different contraceptive methods in longitudinal studies.

  2014cites this paper